Can complexity be commercialized?

Nature Biotechnology

Volumn 22, Issue 10, 2004, Pages 1223-1229

  Mack, George S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL; REVIEW; SYSTEM ANALYSIS;

COMMERCE; DRUG EVALUATION; DRUG INDUSTRY; INVESTMENTS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; SYSTEMS BIOLOGY;

EID: 5044232226     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt1004-1223     Document Type: Review

References (1)

1. Skomorovski, K. et al. New TPO treatment schedules of increased safety and efficacy: pre-clinical validation of a thrombopoiesis simulation model. British J. Haematol. 123, 683-691 (2003).